| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC3569 |
| Trial ID | NCT06010862 |
| Disease | Gastric Cancer | Colon Cancer | Pancreas Cancer | Esophagus Cancer | Cholangiocarcinoma | Lung Cancer | Breast Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Safety and Efficacy Clinical Study of CEA-targeted CAR-T Therapy forCEA-positive Advanced/Metastatic Malignant Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC051 |
| Cohort 1 | |||||||||||
|
|||||||||||